Creative Planning
TPST icon

Creative Planning’s Tempest Therapeutics TPST Stock Holding History

Creative Planning’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Hold
0
– – – 3562
2017
Q2 		– Hold
0
– – – 4831
2017
Q1 		– Hold
0
– – – 4907
2016
Q4 		– Hold
0
– – – 4833
2016
Q3 		– Hold
0
– – – 4130
2015
Q1 		– Sell
-5
Closed -$624K – 4405
2014
Q4 		$624K Buy
+5
New +$366K 0.01% 611

Other funds holding TPST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Creative Planning's TPST Position: Q3 2017 in Review

Creative Planning held its Tempest Therapeutics (TPST) position steady in Q3 2017 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3562.

Creative Planning first reported a position in TPST in Q4 2014 and has held it in 1 quarter since. The position peaked at $624K in Q4 2014. 47 funds tracked by Wall St. Rank hold TPST as of Q3 2017.

  • Creative Planning held 0 shares of Tempest Therapeutics worth $0 as of Q3 2017.
  • Creative Planning left its Tempest Therapeutics share count unchanged in Q3 2017.
  • Tempest Therapeutics made up ﹤0.01% of Creative Planning's portfolio in Q3 2017, its #3562 holding.
  • Creative Planning first reported a position in Tempest Therapeutics in Q4 2014 and has held it in 1 quarter since.
  • Creative Planning's Tempest Therapeutics position peaked at $624K in Q4 2014.
  • 47 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.